Tube Investments of India Ltd has scheduled an earnings conference call for analysts and investors on Friday, 13th May 2026, at 4:30 PM IST. The call will be held following the announcement of the company's audited financial results for the financial year ended 31st March 2026. The event will be conducted as a group call and will include an interactive Question & Answer session with the management.

Conference Call Details

The company filed an intimation with both the National Stock Exchange of India Ltd and BSE Limited on 6th May 2026, under Regulations 30 & 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was signed by S. Krithika, Company Secretary of Tube Investments of India Ltd. The conference call is being organised to discuss the company's earnings performance for Q4FY26.

The following table summarises the key details of the scheduled conference call:

Management Participants

The conference call will see participation from senior leadership across the company's key functions and divisions. The following management representatives are scheduled to participate:

• Mr. M A M Arunachalam – Executive Chairman
• Mr. Vellayan Subbiah – Vice Chairman
• Mr. Mukesh Ahuja – Managing Director
• Mr. AN Meyyappan – Chief Financial Officer
• Mr. Shivdeep Singh Jammu – Division Head, TPI
• Mr. M. Sivakumar – Division Head, MFPD
• Mr. U. Rajagopal – Division Head, TI Cycles

The participation of division heads alongside the top management underscores the comprehensive nature of the earnings discussion, covering multiple business segments of the company.

Regulatory Filing

The intimation was submitted in compliance with SEBI's listing obligations framework. The filing was made to both major stock exchanges on 6th May 2026, ensuring timely disclosure to market participants ahead of the scheduled results and analyst interaction. Investors and analysts seeking further information may contact Joseph George at joseph.george@iiflcap.com or at +91 22 4646 4667.

Tube investment has announced an incremental investment of Rs 75 crore in its subsidiary 3xper Innoventure Limited through subscription of Compulsorily Convertible Preference Shares (CCPS). The company entered into a supplementary agreement on 23rd April 2026 with 3xper Innoventure Limited and Mr. N Govindarajan for this strategic investment.

Investment Structure and Details

The total fund raising initiative amounts to Rs 100 crore, with Tube Investments of India Limited contributing Rs 75 crore and Mr. N Govindarajan investing Rs 25 crore. The investment will be made through subscription of CCPS at face value of Rs 100 per share.

Current Shareholding Structure

3xper Innoventure Limited is a subsidiary of Tube Investments of India Limited. The company currently holds significant stakes in 3xper through both equity shares and preference shares.

Business Operations and Strategic Purpose

3xper Innoventure Limited operates in the pharmaceutical industry with a focus on Contract Development and Manufacturing Operations (CDMO). The proposed fund raising is strategically designed to scale up the operations of 3xper and its subsidiary, enhancing their capabilities in the pharmaceutical manufacturing sector.

The investment represents a related party transaction as 3xper is a subsidiary of Tube Investments of India Limited. However, the CCPS subscription will be made at face value, ensuring transparent pricing for the transaction.

Regulatory Compliance

The disclosure has been made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and the SEBI Master Circular dated 30th January 2026. The closing of the transaction is subject to satisfactory completion of conditions precedent as contained in the supplementary agreement executed between the parties.

The supplementary agreement retains the significant terms of investment for CCPS while other terms remain as per the original agreement between the parties. This structured approach ensures continuity in the business relationship while facilitating the additional capital infusion required for expansion.